4-(3,4-Dimethoxy-phenyl)-thiazol-2-ylamine | CAS 51837-85-5

Element: dimethoxy thiazol ylamine phenyl

Page Content Identification Properties Suppliers Prices & Availability Get Quick Quote ☰

Identification Properties Suppliers Prices & Availability Get Quick Quote

C-S » Chemicals » dimethoxy-phenyl-thiazol-ylamine-PX88217

Identification

4-(3,4-Dimethoxy-phenyl)-thiazol-2-ylamine

CAS:

51837-85-5

EINECS:

Molecular Formula:

C₁₁H₁₂N₂O₂S

MDL:

MFCD01088726

SMILES:

COC1=C(C=C(C=C1)C2=CSC(=N2)N)OC

Synonym:

4-(3,4-dimethoxy-phenyl)-thiazol-2-ylamine ; 4-(3,4-dimethoxyphenyl)-1,3-thiazol-2-amine ; 4-(3,4-dimethoxyphenyl)thiazol-2-amine ; iflab-bb f1386-0384 ; 4-(3,4-dimethoxyphenyl)-1,3-thiazol-2-amine(saltdata: free) ; chembrdg-bb 6872713 ; 2-thiazolamine, 4-(3,4-dimethoxyphenyl)- ; 4-(3,4-dimethoxyphenyl)-2-thiazolamine

Suppliers

Santa Cruz Biotechnology, Inc.

314420

Get Quick Quote

CAS equal suppliers

4-(3,4-Dimethoxyphenyl)-1,3-thiazol-2-amine

Santa Cruz Biotechnology, Inc.

SCB645025800

4-(3,4-Dimethoxyphenyl)-1,3-thiazol-2-amine

Key Organics Limited

MS-11000

Prices & Availability

Data is processed

Properties for 4-(3,4-Dimethoxy-phenyl)-thiazol-2-ylamine

Molecular Weight:

236.29 g·mol−1

Hazard Statements

GHS03
Harmful

Acute toxicity (oral, dermal, inhalation), category 4
Skin irritation, categories 2, 3
Eye irritation, category 2A
Skin sensitization, category 1
Specific target organ toxicity following single exposure, category 3
- Respiratory tract irritation
- Narcotic effects

Not used

with the "skull and crossbones" pictogram
for skin or eye irritation if:
the "corrosion" pictogram also appears
the "health hazard" pictogram is used to indicate respiratory sensitization

Safety & Transport Information

Hazard Classes:

irritant

Hazard Symbols:

Alternative Distributors of [4-(3,4-Dimethoxy-phenyl)-thiazol-2-ylamine]

Producers or manufacturers change the product range from time to time. The following companies
have appeared as suppliers in the past / currently not verified

Suzhou Rovathin Pharmatech Co., Ltd